SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Who pays when an AI agent tries again?

Brandlight helps enterprise marketers manage how AI recommends their brand

BlueGreen Water Technologies turns algae blooms into large-scale carbon removal

Taboola to acquire Dianomi for up to £27 million as it pushes deeper into finance advertising

Buzz

Most popular

Daily

Weekly

1

Serbia opens Israeli drone factory as defense ties with Elbit deepen

2

The man who helped build Palo Alto’s Cortex is leaving the company

3

“Our next milestone will be a billion-dollar valuation”: MIND triples valuation to $300 million with $72 million Series B

4

How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit

5

Sayeret Matkal veterans raise $22 million to teach the world English with AI

Mileutis

2 stories about Mileutis

דוד וחוזה איצקוביץ מילאוטיס

The Israeli startup combating drug-resistant bacteria

24.10.21|Yafit Ovadia

“Some 70% of antibiotics worldwide are administered to animals, and affected pathogens may later develop antimicrobial resistance and enter the environment, affecting humans,” says David Javier Iscovich, the CEO of Mileutis, which has developed an antibiotic-alternative for dairy cows and animal health

Why is Covid-19 not as bad as previous crises and who raised $20 million?

CTech Daily Roundup: Israeli tech companies pouncing on free Wall Street money